Acute Leukemias Flashcards
Acute Leukemias
stem cell disorders characterized by malignant neoplastic proliferation & accumulation of immature & nonfunctional hematopoietic cells in the BM
Acute Leukemia General Characteristics
Abrupt onset & progresses rapidly
symptoms are related to the anemia, thrombocytopenia &/or neutropenia
BLASTS ARE ALMOST ALWAYS FOUND IN PB
2 categories
AML vs ALL
AML- affects the maturation of myeloid stem cells
ALL- affects the lymphoid progenitor
Acute Leukemia FAB criteria
morphological & cytochemical evaluation
>30% blasts
Acute Leukemia WHO criteria
morphology, cytogenetics, molecular genetics, & immunologic markers
>20% blasts
Acute Lymphoblastic Leukemias
malignant lymphocytes that do not mature & do not undergo apoptosis
Epidemiology of ALL
L1 - most common leukemia of children
L2 & L3 - seen in children & adults
ALL clinical Findings
normo, normo anemia thrombocytopenia bone pain usually neutropenia WBC - increased, normal, decreased LYMPHOBLASTS - no auer rods & scant cytoplasm
ALL BM findings
hypercellular
>20% lymphoblasts
ALL stain reactions
myeloperoxidase -
sudan black B -
chloroacetate esterase -
ALL L1 General Characteristics
most common ALL in children - peak age is 2-6
best prognosis
majority of ALL cases
ALL L1 Morphology
lymphoblasts predominantly small (2x mature lymph)
nuclear shape is regular
nucleoli are NOT prominent
cytoplasm is scant & only moderately basophilic
ALL L2 General Characteristics
most frequent ALL found in adults
large lymphoblasts
ALL L2 morphology
LARGE lymphoblasts
nuclear shape is irregular w/ indentations
nucleoli are large & prominent
cytoplasm size & color is variable
ALL L3 General Characteristics
rarest form of ALL
known as BURKITT’S lymphoma/leukemia
presents more often as a lymphoma
occurs in both children & adults
ALL L3 morphology
Large lymphoblasts nuclear shape is regular nucleoli is prominent cytoplasm is abundant & deeply basophilic VACUOLIZATION
WHO classification of ALL
- precursor B & precursor T cell neoplasms
2. Burkitt type (L3)
Precursor B-Cell Leukemia
B-Cell ALL or B-ALL
80-85% of ALL cases in children
70% of cases in adults